ADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast Cancer

(MedPage Today) — CHICAGO — First-line trastuzumab deruxtecan (T-DXd) combined with pertuzumab (Perjeta) improved progression-free survival (PFS) in HER2-positive locally advanced or metastatic breast cancer, according to the DESTINY-Breast09…

Source link : https://www.medpagetoday.com/meetingcoverage/asco/115844

Author :

Publish date : 2025-06-02 12:00:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
	1	2	3	4	5	6
7	8	9	10	11	12	13
14	15	16	17	18	19	20
21	22	23	24	25	26	27
28	29	30	31

ADC-Pertuzumab Promising as New Standard in HER2-Positive Metastatic Breast Cancer

Adjuvant Nivolumab + CRT Improves DFS in HNSCC

AI Algorithm Predicts Transfusion Need in Acute GI Bleeds

Related Posts

At Least 60% of Liver Cancers Tied to Preventable Risk Factors

Delivering the World’s Most Premature Baby, as Told by the Medical Team

Vaping Up Slightly While Heavy Alcohol Use Down a Little, SAMHSA Report Finds

HTO May Slow Knee OA Progression in Bowlegged Patients

Realignment Surgery Definitely Helps in Knee OA, Trial Indicates

RFK Jr. Says He’s Going to Overhaul Vaccine Injury Program

At Least 60% of Liver Cancers Tied to Preventable Risk Factors

Delivering the World’s Most Premature Baby, as Told by the Medical Team

Vaping Up Slightly While Heavy Alcohol Use Down a Little, SAMHSA Report Finds

HTO May Slow Knee OA Progression in Bowlegged Patients

Realignment Surgery Definitely Helps in Knee OA, Trial Indicates

RFK Jr. Says He’s Going to Overhaul Vaccine Injury Program

UV Lights Might Modestly Reduce Nursing Home Respiratory Infections

Novel Anti-Amyloid Drug Aims to Outperform Current Standards

Categories

Archives